YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) AI Stock Analysis

• Market Cap: ¥8.62B
• Dividend Yield: 1.87%
• Average Volume (3M): 626.00
• Price to Earnings (P/E): 20.3
• Beta (1Y): 0.52
• Revenue Growth: 2.65%
• EPS Growth: 8.83%
• Country: JP
• Employees: 606
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Distribution
• EPS (TTM): N/A
• Shares Outstanding: 2,553,000
• 10 Day Avg. Volume: 310
• 30 Day Avg. Volume: 626
• PEG Ratio: 1.10
• Price to Book (P/B): 0.71
• Price to Sales (P/S): 0.10
• P/FCF Ratio: 18.99
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: ¥3,609.00 ▲(10.20% Upside)

The score is led by strong financial stability (notably zero debt) and improving revenue growth, supported by constructive technical trends (price above key moving averages and positive MACD). Offsetting factors are very thin margins and a recent deterioration in cash conversion, while valuation is reasonable but not especially cheap and the dividend is modest.

Positive Factors

Debt-Free Balance Sheet

A debt-free balance sheet provides high financial flexibility and reduces risk, allowing the company to invest in growth opportunities without the burden of interest payments.

Revenue Growth Acceleration

Accelerating revenue growth indicates strong demand and effective business strategies, positioning the company well for future expansion in the competitive medical distribution industry.

Equity Growth

Rising equity enhances the company's asset base and financial stability, providing a solid foundation for sustainable growth and resilience against economic fluctuations.

Negative Factors

Thin Profit Margins

Low net margins limit the company's ability to absorb cost increases or pricing pressures, potentially impacting long-term profitability and competitive positioning.

Cash Conversion Deterioration

Declining cash conversion efficiency can strain liquidity and limit the company's ability to reinvest in growth initiatives, posing a risk to financial health if not addressed.

Volatile Operating Profit

Inconsistent operating profit growth suggests challenges in managing costs or pricing, which could hinder the company's ability to sustain profitability in the face of market changes.

YAMASHITA HEALTH CARE HOLDINGS, INC. Business Overview & Revenue Model

Company Description

Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, calculus crushing devices, and stents. It also provides consulting services related to the management of medical and long-term care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.

How the Company Makes Money

YAMASHITA HEALTH CARE HOLDINGS, INC. generates revenue primarily through the sale of medical supplies and equipment. The company maintains partnerships with manufacturers to distribute a wide array of products to healthcare facilities. Revenue streams include direct sales to hospitals and clinics, as well as long-term supply contracts with healthcare institutions. Additionally, the company may engage in value-added services such as equipment maintenance and consulting, contributing to diversified income sources.

YAMASHITA HEALTH CARE HOLDINGS, INC. Financial Statement Overview

Summary

Financial health is supported by a debt-free balance sheet and steadily rising equity. Revenue growth has improved (mid-single digits historically, ~12% most recently), but profitability remains thin (~1% net margin) and EBIT has not consistently expanded. Cash flow stays positive, yet cash conversion weakened sharply in the latest year (FCF ~55% of net income), adding some quality risk.

Income Statement

Revenue growth has been steady over the last three years (about mid-single digits), accelerating to ~12% in the latest annual period. Profitability is modest—gross margin is stable around 13–14%, but net margin remains low at ~1%, typical of distribution but still leaves limited cushion. Earnings have improved versus 2023, yet operating profit has not consistently expanded (EBIT down from 2023 levels), indicating some ongoing cost/price pressure.

Balance Sheet

The balance sheet is a clear strength: total debt is reported at zero across all periods, resulting in no leverage-driven risk and high financial flexibility. Equity has been trending up over time, supporting growth in the asset base. Returns on equity are reasonable in the most recent two years (~7%), though they have been volatile historically (notably weaker in 2023), suggesting profitability can swing with operating conditions.

Cash Flow

Cash generation is positive, with free cash flow consistently positive, but volatility is a key watch-out. After very strong cash flow in 2023, both operating and free cash flow fell sharply in the latest year, and free cash flow covered only ~55% of net income most recently (down from ~91–96% in the prior two years). This points to less efficient cash conversion lately, even though the company remains cash-flow positive.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	64.38B	64.49B	61.55B	58.20B	55.15B	70.13B
Gross Profit	8.74B	8.57B	8.50B	8.05B	7.72B	7.51B
EBITDA	1.03B	1.17B	1.09B	840.00M	1.25B	1.25B
Net Income	531.00M	616.00M	580.00M	219.00M	696.00M	678.49M
Balance Sheet
Total Assets	25.20B	27.55B	26.56B	24.57B	24.09B	24.32B
Cash, Cash Equivalents and Short-Term Investments	3.24B	5.70B	5.30B	5.83B	3.98B	3.65B
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	16.25B	18.56B	18.00B	16.64B	16.08B	16.74B
Stockholders Equity	8.94B	8.98B	8.54B	7.91B	7.98B	7.58B
Cash Flow
Free Cash Flow	0.00	338.00M	801.00M	2.08B	462.71M	765.29M
Operating Cash Flow	0.00	617.00M	878.00M	2.17B	581.27M	911.53M
Investing Cash Flow	0.00	19.00M	-1.07B	-107.00M	-27.66M	-134.14M
Financing Cash Flow	0.00	-240.00M	-335.00M	-209.00M	-230.00M	-137.81M

YAMASHITA HEALTH CARE HOLDINGS, INC. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3275.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9265, the sentiment is Positive. The current price of 3275 is below the 20-day moving average (MA) of 3296.75, above the 50-day MA of 3273.90, and above the 200-day MA of 3008.70, indicating a bullish trend. The MACD of 18.87 indicates Negative momentum. The RSI at 64.71 is Neutral, neither overbought nor oversold. The STOCH value of 61.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9265.

YAMASHITA HEALTH CARE HOLDINGS, INC. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3183	74 Outperform	¥38.01B	17.21	―	3.97%	6.63%	11.04%
2689	71 Outperform	¥12.87B	10.16	―	3.90%	3.64%	-4.70%
9265	70 Outperform	¥8.62B	20.35	―	1.87%	2.65%	8.83%
7079	69 Neutral	¥6.66B	9.10	―	3.00%	2.21%	-22.75%
3151	67 Neutral	¥63.08B	6.87	―	4.22%	2.23%	72.07%
2183	52 Neutral	¥7.02B	-5.92	―	5.44%	-15.42%	-879.08%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%